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levels of Helix-II measured by a new ELISA and radiological
progression in patients with knee OA followed prospectively for 5
years.
Methods: Eighty-three patients with persistent pain (> 3 months)
in one or both knees were included [54% female, mean age;
62 yr; Kellgren-Lawrence scores: 0 (13%), I (5%), II (4%), III
(77%), IV (1%)]. Serum for measurements of Helix-II and urinary
CTX-II were measured at baseline, 2 yr, 3 yr and 5 yr and
knee radiographs were obtained at baseline and 5 yr. Disease
progression was deﬁned as either a reduction in the tibiofemoral
joint space by at least 2 mm or total knee replacement of either
knee during the 5-year follow-up.
Results: During the 5-year follow-up, 24 patients had a radi-
ological progression and 59 did not progress. Serum Helix-II
increased during follow-up (10%/yr, p=0.0032) and mean 5-year
levels were higher in progressors than non-progressors (+30%,
p=0.0345). When used as a continuous variable, each SD in-
crease of mean 5 year serum Helix-II levels was associated
with an age-sex-BMI adjusted relative risk (RR) of progression
of 1.69 (95% conﬁdence interval: 1.01-2.81). In a multiple lo-
gistic regression model, both serum Helix-II and urinary CTX-II
were independently associated with disease progression. Pa-
tients with high serum Helix-II (highest quartile) and high urinary
CTX-II (above median) had an 8 fold higher risk of radiological
progression [RR: 7.79 (1.77-34.2)].
Conclusions: Increased serum Helix-II levels are associated
with a higher risk of radiological progression in knee OA in-
dependent of urinary CTX-II, suggesting that the two type II
collagen degradation markers reﬂect complementary biological
pathways of cartilage degradation. Overall, our data suggest that
the combination of serum Helix-II and urinary CTX-II would be a
more powerful predictor of disease outcome in knee OA.
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Purpose: To examine type II collagen content and denaturation
and their relationship in hip cartilages. The occurrence of similar
collagen molecule damage in knee and hip OA cartilage supports
the contention that collagen damage is a common feature in joint
disease.
Methods: 21 OA (aged 45 to 89 years, 13 women) and 26
reference (aged 55 to 99 years, 20 women) femoral heads
collected at total hip replacement surgery or in femoral neck
fracture patients were kept frozen at -80oC until analysis.
In OA, cartilage was sampled from areas that had full-thickness
cartilage whereas the reference cartilage was taken from the
superior mostly loaded area of femoral head. A small amount
of the 50 mg from each hip sampled cartilage was used for
routine histology to examine degradatavie changes according
to Mankin grading system (0-13). Each freeze- dried cartilage
sample was treated with 1mg/ml α-Chymotrypsin in 50 mM Tris
containing the proteinase inhibitors to extract denatured collagen.
The supernatants and residues were hydrolysed in 6N HCl at
110°C overnight, and then freeze-dried. These samples were
dissolved in 500µl of distilled water and clariﬁed using equal
amount of charcoal and AG-1 X8 anion exchange resin. The
amount of hydroxyproline was measured at 550 nm absorbance
by colorimetry. The L-4- Hyroxyproline was used as standard.
Results: The reference group was older than OA group
(p<0.001).
The median Manking grade in OA and reference samples were
4.5 (range 1-8) and 1 (range 0-3), respectively. In OA cartilage,
the collagen content was about 9% lower than that of reference
cartilages (1830 µg/ml vs. 2009 µg/ml, P=0.015). The proportion
of degraded collagen was almost four times higher in OA than
that of reference cartilages (3.7 vs. 1.1%) (P≤0.001).
There was no difference between men and women in collagen
content or degraded collagen in any of the groups.
There were no relationship between age and total collagen
content and no positive relationships between percent of collagen
denaturation and age in in reference or OA cartilages.
There was an inverse relationship between the percentages of
degraded collagen and collagen content in OA cartilage (r=-0.66,
p=0.001). In contrast, no obvious relationship between degraded
collagen and collagen content was present in the reference group
(p=0.17).
Conclusions: In the present study we extend previous ﬁndings of
increased amount of collagen degradation in knee OA and show
that similar changes also occur in hip OA. We also conﬁrm an
inverse relationship between collagen denaturation and content
in hip OA. The latter may represent a molecular explanation to
OA progression. At a higher rate of type II collagen damage,
lesser amount of collagen is maintained in the tissue. A possible
mechanism behind this is that released molecular fragments
may stimulate further extracellular matrix degradation causing
a vicious circle. This seems disease speciﬁc since an inverse
relationship between collagen degradation and content was not
obvious in reference cartilage.
Age is commonly discussed as a risk factor for OA since the
frequency of OA increases as population ages. In this study, col-
lagen content and degradation was not signiﬁcantly affected by
age. It suggests that OA may develop independently of age and
that OA in elder people may merely depend on long exposure
time to risk factors rather than age per se. In conclusion, the
present study provides new perspectives of cartilage collagen
metabolism in human OA cartilage. Similar molecular changes
occur in hip and knee OA cartilage seemingly without relation to
age. Therapeutic interventions in order to control joint cartilage
collagen content using inhibitors that decrease collagen degra-
dation ould be considered in the management of progressive hip
and knee OA.
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Purpose: Ageing is the primary risk factor for osteoarthritis (OA).
Chondrocytes in OA show a deviant behavior that resembles ter-
minal differentiation of growth-plate chondrocytes, characterized
by elevated MMP-13 expression. Previously we have demon-
strated a reduction in TGF-beta signaling via the ALK5 receptor
in aged mice and experimental OA. ALK5 activates the Smad2/3
route, which is known to suppress terminal differentiation. Re-
cently, it has been shown that in certain cell types TGF-beta is
also able to activate the Smad1/5/8 route via the ALK1 recep-
tor. This route has been shown to induce chondrocyte terminal
differentiation. We investigated whether during ageing and OA,
TGF-beta signaling switches from ALK5 to ALK1, favoring pro-
gression of chondrocyte differentiation.
Methods: We investigated whether TGF-beta signals via ALK5
or ALK1 in chondrocytes by Western blotting. To assess whether
ALK5 and ALK1 were speciﬁc for Smad2/3 or Smad1/5/8 re-
spectively, chondrocytes were transfected with Ad-caALK5 or
Ad-caALK1 after which a Western Blot was performed. Further-
